These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 26433848

  • 1. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA.
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 4. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR, Baron ED, Masten S, Cooper KD.
    Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.
    Lewis DJ, Duvic M.
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28338261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P, Knobler R, Fierro MT, Savoia P, Marra E, Fava P, Bernengo MG.
    Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
    Sanli H, Akay BN, Anadolu R, Ozcan M, Saral S, Akyol A.
    J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
    [Abstract] [Full Text] [Related]

  • 11. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
    Akilov OE.
    Cells; 2023 Sep 20; 12(18):. PubMed ID: 37759543
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.
    Atzmony L, Amitay-Laish I, Gurion R, Shahal-Zimra Y, Hodak E.
    J Eur Acad Dermatol Venereol; 2015 Dec 20; 29(12):2382-9. PubMed ID: 26299651
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
    Tsirigotis P, Pappa V, Papageorgiou S, Kapsimali V, Giannopoulou V, Kaitsa I, Girkas K, Papageorgiou E, Stavrianeas N, Economopoulos T, Dervenoulas J.
    Br J Dermatol; 2007 Jun 20; 156(6):1379-81. PubMed ID: 17459033
    [No Abstract] [Full Text] [Related]

  • 16. Photochemotherapy for mycosis fungoides: long-term followup study.
    Roenigk HH.
    Cancer Treat Rep; 1979 Apr 20; 63(4):669-73. PubMed ID: 445519
    [Abstract] [Full Text] [Related]

  • 17. Photopheresis therapy for cutaneous T-cell lymphoma.
    Duvic M, Hester JP, Lemak NA.
    J Am Acad Dermatol; 1996 Oct 20; 35(4):573-9. PubMed ID: 8859287
    [Abstract] [Full Text] [Related]

  • 18. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD, Licata AL, Braverman IM, Edelson RL, Heald PW, Feldman AM, Kacinski BM.
    Int J Radiat Oncol Biol Phys; 1995 Jul 15; 32(4):987-95. PubMed ID: 7607973
    [Abstract] [Full Text] [Related]

  • 19. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.
    Rubio-Muniz CA, Sánchez-Velázquez A, Arroyo-Andrés J, Agud-de Dios M, Tarín-Vicente EJ, Falkenhain-López D, Ortiz-Romero PL.
    J Eur Acad Dermatol Venereol; 2024 Jan 15; 38(1):e102-e105. PubMed ID: 37611255
    [No Abstract] [Full Text] [Related]

  • 20. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA.
    Curr Opin Oncol; 2012 Jan 15; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.